Profile
Michael G.
Layman is currently the Chief Executive Officer at Emerald Shoals Targeted Opportunities Fund LP, Chairman & Managing Director at LF Athens Capital LLC, Independent Director at Land Betterment Corp., and Director at Clarametyx Biosciences, Inc. He previously served as an Independent Director at American Resources Corp.
(Indiana) from 2020 to 2023.
Layman received his undergraduate degree from Otterbein College.
Michael Layman active positions
| Companies | Position | Start |
|---|---|---|
Emerald Shoals Targeted Opportunities Fund LP | Chief Executive Officer | - |
Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Director/Board Member | - |
LF Athens Capital LLC
LF Athens Capital LLC Investment ManagersFinance Functions as private equity fund | Chief Executive Officer | - |
Land Betterment Corp.
Land Betterment Corp. Miscellaneous Commercial ServicesCommercial Services Operates as an environmental solutions company | Director/Board Member | - |
Former positions of Michael Layman
| Companies | Position | End |
|---|---|---|
| AMERICAN RESOURCES CORPORATION | Director/Board Member | 2023-09-05 |
Training of Michael Layman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 6 |
|---|---|
Otterbein College
Otterbein College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Resources Corp. (Indiana)
American Resources Corp. (Indiana) CoalEnergy Minerals Engages in coal mining and processing operations | Energy Minerals |
Emerald Shoals Targeted Opportunities Fund LP | |
Land Betterment Corp.
Land Betterment Corp. Miscellaneous Commercial ServicesCommercial Services Operates as an environmental solutions company | Commercial Services |
Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Health Technology |
LF Athens Capital LLC
LF Athens Capital LLC Investment ManagersFinance Functions as private equity fund | Finance |
- Stock Market
- Insiders
- Michael Layman
















